 BYSI | BeyondSpring, Inc. Company profile
Company profileBeyondSpring is a global, clinical-stage biopharmaceutical company focused on the development of innovative cancer therapies. Its lead asset, immuno-oncology agent Plinabulin, is currently in multiple global registration studies, for the prevention of chemotherapy-induced neutropenia and as an anticancer agent in combination with docetaxel in advanced non-small cell lung cancer (NSCLC). Address28 Liberty Street Products & Services
Videos about BeyondSpring, Inc. | NotesJump to (Finance sites)         ResearchInvestor pageir.beyondspringpharma.comIf you are looking for News & events, Press Release, they are available on their Investors Relationssite. Other stocks            Support this projectIf you want to help pay for server cost or for improving this tool. You can send it via Paypal. Social MediaRecommended Books Buy on Amazon Want to know the strategies of successful swing trading? This friendly guide covers the ins and outs of this risky but profitable investing approach, explaining all the basics in plain English. You'll see how to use the two investment approaches - technical and fundamental analysis - to indentify promising securities in strongly trending markets. In addition, this guide covers how to calculate investment returns and, most important, how to manage your portfolio's risk. Take advantage of price swings in strongly trending securities and pump up your portfolio! |
